ALISON GRANT: Open Payments
NPI 1487279865 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,828 in 106 payments from 17 companies in 2025. Trend: 2023 $1,781 · 2024 $2,950 · 2025 $2,828
Food & beverage: $2,741Education: $87
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $793 |
| ABBVIE INC. | 17 | $437 |
| Janssen Biotech, Inc. | 24 | $412 |
| Galderma Laboratories, L.P. | 9 | $229 |
| Regeneron Healthcare Solutions, Inc. | 8 | $186 |
| LEO Pharma Inc. | 3 | $144 |
| Incyte Corporation | 5 | $139 |
| UCB, Inc. | 5 | $113 |
| Amgen Inc. | 3 | $80 |
| GENZYME CORPORATION | 3 | $72 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Rhapsido, NEMLUVIO, RINVOQ, ADBRY, OPZELURA.
Industry payments across VA — which companies pay providers there.
